| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 122 |
| 1 | PREDNISOLONE | 96 |
| 2 | PREDNISOLONE ORAL | 96 |
| 3 | PREDNISOLONE ORAL SOLUTION | 96 |
| 4 | TACROLIMUS | 85 |
| 5 | DEXAMETHASONE | 82 |
| 6 | MYCOPHENOLATE MOFETIL | 77 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 77 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 77 |
| 9 | TACROLIMUS OINTMENT 0.1% | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LULICONAZOLE | 2 | 0.0114 |
| 1 | DEXCHLORPHENIRAMINE MALEATE | 8 | 0.0080 |
| 2 | FOSCARNET SODIUM | 32 | 0.0079 |
| 3 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 2 | 0.0054 |
| 4 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 5 | GANCICLOVIR SODIUM | 41 | 0.0038 |
| 6 | TROPICAMIDE | 6 | 0.0037 |
| 7 | FAMCICLOVIR | 10 | 0.0036 |
| 8 | CABAZITAXEL | 12 | 0.0034 |
| 9 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 54 | 0.0024 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 22 | 0.0017 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 6 | 0.0014 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 18 | 0.0008 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 18 | 0.0007 |
| 6 | Anticholinergic [EPC] | 10 | 0.0006 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 8 | Polyene Antifungal [EPC] | 22 | 0.0005 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 25 | 0.0005 |